(Q57579656)
Statements
Multicenter phase II trial of neoadjuvant therapy with trastuzumab, docetaxel, and carboplatin for human epidermal growth factor receptor-2-overexpressing stage II or III breast cancer: results of the GETN(A)-1 trial (English)
Remy Largillier
Laurent Arnould
Philippe Chollet
Mario Campone
David Coeffic
Frank Priou
Xavier Martin
Véronique Trillet-Lenoir
Béatrice Weber
Jean Pierre Bleuse
Berangère Vasseur
Daniel Serin
Moïse Namer